MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Masimo Company Profile (NASDAQ:MASI)

Consensus Ratings for Masimo (NASDAQ:MASI) (?)
Ratings Breakdown: 1 Hold Rating(s), 4 Buy Rating(s)
Consensus Rating:Buy (Score: 2.80)
Consensus Price Target: $50.75 (3.36% downside)

Analysts' Ratings History for Masimo (NASDAQ:MASI)
Show:
DateFirmActionRatingPrice TargetActions
6/1/2016Raymond JamesDowngradeStrong-Buy -> OutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/5/2016WedbushBoost Price TargetOutperform$51.00 -> $57.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/5/2016Piper JaffrayUpgradeNeutral -> Overweight$43.00 -> $52.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/5/2016Roth CapitalBoost Price TargetBuy$40.00 -> $50.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/1/2016BTIG ResearchReiterated RatingNeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/9/2015Off Wall StreetReiterated RatingSellView Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/11/2014Citigroup Inc.Reiterated RatingNeutral$29.00 -> $27.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/8/2014BMO Capital MarketsLower Price Target$26.00 -> $24.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/1/2014 forward)
Earnings History for Masimo (NASDAQ:MASI)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
8/2/2016        
5/4/2016Q116$0.43$0.53$165.25 million$171.20 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/23/2016Q415$0.39$0.15$164.25 million$167.30 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/5/2015Q315$0.31$0.36$149.31 million$152.60 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/4/2015Q215$0.32$0.36$147.93 million$155.73 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/6/2015Q115$0.35$0.41$151.00 million$154.54 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/17/2015Q414$0.37$0.40$159.45 million$161.80 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/29/2014Q314$0.25$0.27$144.20 million$144.10 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/7/2014Q214$0.29$0.24$145.76 million$140.92 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/30/2014Q114$0.29$0.30$144.01 million$139.80 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/13/2014Q413$0.31$0.31$148.25 million$134.70 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/30/2013Q313$0.26$0.27$132.47 million$131.40 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/31/2013Q2 2013$0.28$0.30$136.36 million$137.42 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/2/2013Q1 2013$0.28$0.28$134.46 million$135.90 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/14/2013Q4 2012$0.29$0.26$129.09 million$132.20 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/1/2012Q312$0.26$0.26$120.99 million$112.10 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/1/2012$0.28$0.27ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/2/2012$0.28$0.27ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/14/2012$0.23$0.23ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/25/2011$0.27$0.24ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/9/2011$0.28$0.28ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/3/2011$0.30$0.30ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/15/2011$0.26$0.29ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)
Earnings Estimates for Masimo (NASDAQ:MASI)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20165$0.40$0.43$0.42
Q2 20164$0.41$0.42$0.41
Q3 20164$0.40$0.40$0.40
Q4 20165$0.46$0.49$0.48
(Data provided by Zacks Investment Research)
Dividend History for Masimo (NASDAQ:MASI)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for Masimo (NASDAQ:MASI)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
6/7/2016Joe E KianiCEOSell65,048$50.00$3,252,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/3/2016Joe E KianiCEOSell234,952$50.09$11,768,745.68View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/1/2016Jon ColemanInsiderSell4,000$50.00$200,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/31/2016Raad Mark DeCFOSell40,000$49.43$1,977,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/25/2016Rick FishelInsiderSell25,000$49.85$1,246,250.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/5/2016Jon ColemanInsiderSell8,000$47.00$376,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/28/2016Paul JansenEVPSell10,000$44.88$448,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/27/2016Jon ColemanInsiderSell4,000$44.00$176,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/23/2016Yongsam LeeEVPSell96,000$39.96$3,836,160.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/22/2016Yongsam LeeEVPSell32,000$40.06$1,281,920.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/21/2016Yongsam LeeEVPSell32,000$39.83$1,274,560.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/15/2016Raad Mark DeCFOSell40,000$39.00$1,560,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/29/2016Raad Mark DeCFOSell40,000$38.11$1,524,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/24/2015Jon ColemaninsiderSell10,000$42.00$420,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/9/2015Sanford FitchDirectorSell2,000$41.00$82,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/11/2015Sanford FitchDirectorSell2,000$42.67$85,340.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/6/2015Anand SampathCOOSell45,000$42.00$1,890,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/6/2015Jon ColemaninsiderSell10,000$42.38$423,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/14/2015Sanford FitchDirectorSell2,000$39.29$78,580.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/17/2015Paul JansenEVPSell10,000$42.88$428,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/9/2015Sanford FitchDirectorSell2,000$41.29$82,580.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/31/2015Thomas Samuel McclenahanEVPSell22,000$40.62$893,640.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/26/2015Paul JansenEVPSell10,000$40.88$408,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/22/2015Rick FishelInsiderSell35,084$41.85$1,468,265.40View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/21/2015Joe E KianiCEOSell300,000$40.55$12,165,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/21/2015Steven BarkerDirectorSell20,000$40.00$800,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/8/2015Sanford FitchDirectorSell2,000$38.18$76,360.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/10/2015Sanford FitchDirectorSell2,000$36.49$72,980.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/4/2015Steven BarkerDirectorSell25,000$36.20$905,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/8/2015Sanford FitchDirectorSell2,000$34.57$69,140.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/18/2015Rick FishelInsiderSell18,170$29.85$542,374.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/22/2013Robert ColemanDirectorSell59,400$21.93$1,302,642.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)
Latest Headlines for Masimo (NASDAQ:MASI)
DateHeadline
07/01/16 07:53 AMRecently Issued Stock Ratings For Masimo Corporation (NASDAQ:MASI) - Fiscal Standard
07/01/16 06:44 AMIDEXX: International Growth Strong, Currency Woes Persist -
06/29/16 04:58 PMBrokers Issue Average Price Target Of 40.12 On Masimo Corporation (NASDAQ:MASI) - FTSE News
06/28/16 09:54 AMCapnography Equipment Market - Sidestream Capnographs Dominate Market Owing to Ease of Use
06/28/16 09:54 AMAnesthesia Monitoring Devices Market Worth $USD 1.9 Billion by 2024 - Analysis By Product, End-use & Segment Forecast - Research and Markets
06/28/16 09:54 AMMasimo : Announces FDA 510(k) Clearance for Radius-7® with rainbow® Technology, Including Continuous SpHb®
06/28/16 07:31 AMMasimo Announces FDA 510(k) Clearance for Radius-7® with rainbow® Technology, Including Continuous SpHb® - [at noodls] - http://www.businesswire.com/news/home/20160628005649/en/ Masimo Root with Radius-7 with rainbow (Photo: Business Wire) SpHb monitoring may provide additional insight to the directional trend of hemoglobin ...
06/27/16 04:58 PMVital Signs Monitoring Devices Market to Reach US$ 9.4 Bn by 2025
06/27/16 04:58 PMRising Geriatric Population Base And Spiraling Number Of Surgeries Are Anticipated To Boost The Anesthesia Monitoring Devices Market Growth Till 2024
06/27/16 09:24 AMGlobal Fetal and Neonatal Care Equipment Market Insights, Analysis, Share, Growth Prospects 2022: Acute Market ... - RD News Mag
06/27/16 09:24 AMNext Weeks Broker Price Targets For Masimo Corporation (NASDAQ:MASI) - Fiscal Standard
06/24/16 07:42 AMNeues CT40 Vitalparametergerät von SunTech Medical mit SET® Puls-Oximetrie-Technologie von Masimo ausgestattet - SYS-CON Media (press release)
06/23/16 05:30 PMNew SunTech Medical CT40 Vital Signs Device to Feature Masimo SETR Pulse Oximetry Technology
06/23/16 05:30 PMGlobal fetal and neonatal care equipment market 2021 : size, share, trend, growth, analysis and forecast available in new report
06/23/16 07:49 AMMasimo : New SunTech Medical CT40 Vital Signs Device to Feature Masimo SET® Pulse Oximetry Technology
06/23/16 07:49 AMPress Release from Business Wire : Masimo
06/22/16 04:59 PMRadiometer launches the next generation of transcutaneous monitoring - Cambridge Network
06/22/16 09:45 AMAnesthesia Monitoring Devices Market Worth $1.9 Billion By 2024: Grand View Research, Inc. - PR Newswire (press release)
06/22/16 08:30 AMZacks.com featured highlights: Cable ONE, Masimo, Globant S.A., Altisource Portfolio Solutions S.A. and CommVault Systems -
06/20/16 04:57 PMAnesthesia Monitoring Devices Market Worth $1.9 Billion By 2024: Grand View Research, Inc.
06/20/16 06:16 AMAnesthesia Monitoring Devices Market Worth $1.9 Billion By 2024: Grand View Research, Inc. - PharmiWeb.com (press release)
06/18/16 04:30 PMThe Global Mhealth Market Was Valued $10.5 Billion in 2014 Growing At A CAGR Of 33.5% from 2015 To 2020; Industry Analysis & Opportunities
06/18/16 09:23 AMNew Market Report: Masimo Corporation (MASI) - Financial and Strategic SWOT Analysis Review
06/16/16 09:23 AMBrokers Issue Average Price Target Of 40.12 On Masimo Corporation (NASDAQ:MASI) - Fiscal Standard
06/15/16 05:04 PMRVNC Wrinkled, MRNS Jolted As Study Fails, BSTC Abuzz, FDA Snubs KMPH - Nasdaq
06/15/16 05:04 PMPatient Safety Movement Announces Three New Patient Safety Challenges - Business Wire (press release)
06/15/16 09:42 AMMasimo : Assigned Patent
06/15/16 07:21 AMMasimo O3 Regional Oximetry Device Gets FDA 510 (k) Nod -
06/14/16 09:52 AMMHealth 2016 Global Market Demand,Share,Trends,Insights,Company Profiles and Market Opportunities Research Report Forecasting to 2021
06/14/16 09:52 AMMHealth Market 2016 Global Analysis,Research,Demand & Forecast to 2021 Market Research Report
06/13/16 07:57 AMMasimo Announces 510(k) Clearance for O3™ Regional Oximetry - Business Wire (press release)
06/13/16 07:29 AMMasimo Announces 510(k) Clearance for O3™ Regional Oximetry - [at noodls] - http://www.businesswire.com/news/home/20160613005405/en/ Masimo Root with O3 Regional Oximetry and SedLine Brain Function Monitoring (Photo: Business Wire) O3 regional oximetry uses near-infrared spectroscopy ...
06/13/16 07:17 AMMASIMO (MASI) SHAREHOLDER ALERT – Andrews & Springer LLC Is Investigating Masimo Corporation For Potential Breaches of Fiduciary Duty - [Business Wire] - Andrews & Springer LLC, a boutique securities class action law firm focused on representing shareholders nationwide, is investigating potential breach of fiduciary duty claims against Masimo Corporation .
06/11/16 07:52 AMHealthcare New Highs: Exelixis, Inc. (NASDAQ:EXEL), Press Ganey Holdings, Inc. (NYSE:PGND), Masimo Corporation ... - KC Register
06/09/16 07:54 AMMasimo anuncia lançamento completo de mercado do SpHb® Spot Check Pronto® de próxima geração - EXAME.com
06/08/16 05:25 PMAtheer's AiR Suite Wins "Best Enterprise Solution" at the Auggie Awards at Augmented World Expo 2016 - SYS-CON Media (press release)
06/08/16 05:25 PMIs This the Right Time to Add Masimo Corp (NASDAQ:MASI) to Your Portfolio? - Street Report
06/08/16 07:54 AMMasimo Corp. (MASI) Says Pronto Pulse CO-Oximeter Now under Full Market Release - StreetInsider.com
06/08/16 07:28 AMMasimo Announces Full Market Release of Next Generation SpHb® Spot Check Pronto® - [at noodls] - http://www.businesswire.com/news/home/20160608005479/en/ Pronto Pulse CO-Oximeter with Next Generation SpHb and rainbow DCI-mini Reusable Sensor (Photo: Business Wire) In addition to the Next Generation ...
06/06/16 05:01 PMResearch focused on the study on respiratory care devices market global overview, summary and premium insights forecast to 2020
06/06/16 08:48 AMMasimo Corporation (NASDAQ:MASI) Stock Update & Estimates - Stock Tick Tock
06/05/16 07:46 AMDe Raad Mark, EVP & Chief Financial Officer of Masimo Corporation (NASDAQ:MASI) sells 40,000 shares
06/03/16 07:51 AMMasimo Co. (MASI) Insider Jon Coleman Sells 4000 Shares - Let Me Know About This - Masimo Co. (MASI) Insider Jon Coleman Sells 4000 SharesLet Me Know About ThisMasimo logo Masimo Co. (NASDAQ:MASI) insider Jon Coleman sold 4,000 shares of the company's stock in a transaction that occurred on Wednesday, June 1st. The stock was sold at an average price of $50.00, for a total transaction of $200,000.00.Why Raad De Sold 40000 Stock of Masimo Corporation (NASDAQ:MASI)?HNNMasimo Corp (NASDAQ:MASI) near 52-week high, short interest decreasingStreet Reportall 13 news articles »
06/02/16 07:55 AMMasimo Co. (MASI) Cut to “Outperform” at Raymond James - Let Me Know About This - Masimo Co. (MASI) Cut to “Outperform” at Raymond JamesLet Me Know About ThisMasimo Co. (NASDAQ:MASI) was downgraded by equities research analysts at Raymond James from a “strong-buy” rating to an “outperform” rating in a research report issued on Wednesday, StockTargetPrices.com reports. In other Masimo news, insider Jon ...and more »
06/02/16 07:25 AMOne of India’s Premier Maternal Care Specialists, Motherhood Hospitals, Standardizes on Masimo SET® Technology - [at noodls] - http://www.businesswire.com/news/home/20160602005492/en/ 'We evaluated several technologies and found Masimo SET pulse oximetry to be the most reliable even in the most challenging conditions,' said Dr. ...
06/01/16 05:29 PMMasimo Co. (NASDAQ:MASI) Given Consensus Rating of “Buy” by Brokerages - Let Me Know About This - Masimo Co. (NASDAQ:MASI) Given Consensus Rating of “Buy” by BrokeragesLet Me Know About ThisMasimo logo Masimo Co. (NASDAQ:MASI) has earned a consensus rating of “Buy” from the six research firms that are currently covering the stock. One research analyst has rated the stock with a hold recommendation and five have issued a buy ...and more »
05/26/16 11:20 AMPress Release from Business Wire : Masimo - Times of India - Press Release from Business Wire : MasimoTimes of IndiaMasimo (NASDAQ: MASI) is a global leader in innovative noninvasive monitoring technologies. Our mission is to improve patient outcomes and reduce the cost of care by taking noninvasive monitoring to new sites and applications. In 1995, the company ...and more »
05/26/16 11:20 AMHC Stocks Trading Summary: Masimo Corporation (NASDAQ:MASI), Quest Diagnostics Inc (NYSE:DGX) - share market updates (press release) - HC Stocks Trading Summary: Masimo Corporation (NASDAQ:MASI), Quest Diagnostics Inc (NYSE:DGX)share market updates (press release)“CFSI takes great pride in co-sponsoring the Excellence in Fire Service-Based EMS Awards with Masimo,” said Dr. William F. Jenaway, Ph.D., President of CFSI. “Through this awards program, we are able to recognize innovations in the delivery of ...
05/09/16 10:08 AMMasimo Corp. :MASI-US: Earnings Analysis: Q1, 2016 By the Numbers -
05/09/16 09:14 AMMasimo (MASI): Moving Average Crossover Alert -
About Masimo

Masimo logoMasimo Corporation is a medical technology company that develops, manufactures and markets non-invasive patient monitoring products. The Company's business is measure-through-motion and low-perfusion pulse oximetry monitoring, known as Masimo Signal Extraction Technology (SET) pulse oximetry. Its product offerings include monitoring blood constituents with an optical signature, optical organ oximetry monitoring, electrical brain function monitoring, acoustic respiration monitoring and exhaled gas monitoring. The Company has developed the Root patient monitoring and connectivity platform, the Radical-7 bedside and portable patient monitor and the Radius-7 wearable wireless patient monitor. It has also developed the Patient SafetyNet remote patient surveillance monitoring system, which allows over 200 patients to be monitored simultaneously and remotely through a personal computer (PC)-based viewing station or by care providers through their voice-over-Internet Protocol (IP) phones.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Medical Appliances & Equipment
  • Sub-Industry: Health Care Equipment
  • Exchange: NASDAQ
  • Symbol: MASI
  • CUSIP: 57479510
Key Metrics:
  • Previous Close: $51.56
  • 50 Day Moving Average: $50.213
  • 200 Day Moving Average: $42.356
  • P/E Ratio: 30.946
  • P/E Growth: 1.910
  • Market Cap: $2.57B
  • Current Quarter EPS Consensus Estimate: $1.830 EPS
Additional Links:
Masimo (NASDAQ:MASI) Chart for Friday, July, 1, 2016


            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha